Then take control of your health with Hers and Hims
L-Carnitine supplementation reduces the general fatigue of oncology research models [PMID: 29456846] Laboratory literature summary: L-Carnitine supplementation reduces the general fatigue of oncology research models research subjects during chemotherapy
AOD-9604 has FDA GRAS status for oral fat-loss use only
However, for specific orthopedic models (such as osteoarthritis repair), localized intra-articular administration has also been thoroughly documented. Study Duration Research literature indicates a variety of testing timelines depending on the primary endpoint: Acute Studies: 4 to 12 weeks to observe initial shifts in fat metabolism, plasma glycerol levels, or localized tissue repair

Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.IngredientsBPC 157 (L-Valine L-Glutamine L-Glycine L-Proline L-Lysine L-Alanine L-Arginine L-Histidine L-Leucine L-Tyrosine L-Serine L-Threonine L-Isoleucine L-Trypophan L-Methionine)BPC-159 (L-Valine L-Glutamine L-Glycine L-Proline L-Lysine L-Alanine L-Arginine L-Histidine L-Leucine L-Tyrosine L-Serine L-Threonine L-Isoleucine L-Tryptophan L-Methionine) Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition